JCA Strategy and Planning

Joint Clinical Assessment (JCA) is a transformational change to the access landscape in Europe. It is critical that drug and device developers prepare early and embed JCA requirements into the drug development and evidence generation process. Our team has been actively working on JCA projects and can partner with you to develop your JCA submission strategy, early PICO assessments, and ITC feasibility. We can also provide expertise to support a Joint Scientific Consultation—including ’mock’ JSC—or help you assess your organizational readiness and provide training.